Tuberculosis -- India : Ecology of tuberculosis in India / Bikramaditya K. Choudhary
2021
1
106
Tuberculosis -- India -- Congresses : Facing the reality of drug-resistant tuberculosis in India : challenges and potential solutions : summary of a joint workshop / by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research ; Steve Olson [and others], rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy ; Institute of Medicine of the National Academies
The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test
The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test
The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test
1
117
Tuberculosis -- Law and legislation. : Soft law and global health problems : lessons from responses to HIV/AIDs, malaria, and tuberculosis / Sharifah Sekalala, University of Warwick
2017
1
118
Tuberculosis, Lymph Node. : The royal touch : sacred monarchy and scrofula in England and France. / Translated by J. E. Anderson
1973
1
119
Tuberculosis -- Marshall Islands -- History : Unnatural causes. Collateral damage : is inequality making us sick? / produced by California Newsreel; in association with Vital Pictures; presented by National Minority Consortia; directed and produced by Eric Strange
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
1
121
Tuberculosis, Meningeal : Tuberculous meningitis : manual of diagnosis and therapy / edited by Jerome Hsi-Cheng Chin
2020
1
122
Meninges -- Tuberculosis. : Tuberculous meningitis : manual of diagnosis and therapy / edited by Jerome Hsi-Cheng Chin
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS)
Tuberculosis, Multidrug-Resistant -- epidemiology -- Africa, Southern -- Congresses : Emerging threat of drug-resistant tuberculosis in southern Africa : global and local challenges and solution : summary of a joint workshop / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa
Tuberculosis, Multidrug-Resistant -- prevention & control -- Africa, Southern -- Congresses : Emerging threat of drug-resistant tuberculosis in southern Africa : global and local challenges and solution : summary of a joint workshop / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa
2011
1
134
Tuberculosis, Multidrug-Resistant -- prevention & control -- South Africa -- Congresses : Emerging threat of drug-resistant tuberculosis in southern Africa : global and local challenges and solution : summary of a joint workshop / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa
2011
1
135
Tuberculosis, Multidrug-Resistant -- transmission : Addressing the threat of drug-resistant tuberculosis : a realistic assessment of the challenge : workshop summary / Robert Giffin and Sally Robinson, rapporteurs ; Institute of Medicine of the National Academies
2009
1
136
Tuberculosis, Multidrug-Restant -- drug therapy : Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008 / Steering Group, Ernesto Jaramillo [and others]
